Q1
KEQU — Q1 2026 Financial Report Analysis
Kewaunee Scientific's quarter ended July 31, 2026 (fiscal Q1 2027) saw sales fall 6.7% to $66.3 million and diluted EPS drop 44% to $0.58, driven by flat operating costs on lower revenue and an 8.6-point jump in the tax rate rather than margin erosion, while order backlog fell 17.6% year over year but rose $3.1 million from April.